We combine game-changing MRI analysis with a deep knowledge in disease mechanisms to deliver precise body composition measurements to clinicians and clinical researchers.
2022 campaign includes over 200 candidates in 14 categories. AMRA® MAsS Scan is hopeful to become a finalist in Best New Radiology Software category - no other software segments and quantifies fat and muscle from a whole body scan which takes less than 10 minutes.
Learn what’s new in body composition and how body composition profiling (BCP) with MRI can be used as an effective tool to manage metabolic disease state and guide treatment.
Neuromuscular disorders (NMDs) are generally variably progressing, rare diseases causing devastating skeletal muscle injury resulting in severe disability and even death.
AMRA's webinar with a guest speaker from BioTel Research will bust the myth of MRI (Magnetic Resonance Imaging) being challenging to implement in clinical trials, even in multi-site settings.
AMRA is honoured to have participated in the FSHD International Research Congress 2021. To read more about whole-body MRI in FSHD Clinical Trials right away click the button below.
Recent studies highlight an important and independent relationship between sarcopenia and chronic liver diseases, particularly nonalcoholic fatty liver disease (NAFLD). Learn more from AMRA Medical Research and guest speakers from Virginia Commonwealth University and Axcella Health Inc in this webinar.
The recent development of quantitative MRI biomarkers, describing muscle atrophy and muscle fat replacement, has proven that the effect of disease activity in NMD (Neuromuscular Disorders) can be detected earlier and more precisely when compared to methods aiming at describing functional decline. Learn more in this webinar from AMRA Medical Research and guest speakers from Fulcrum Therapeutics and Pfizer.
In this free webinar we provided an introduction to body composition profiling in clinical trials – how can large scale body composition data enhance the understanding of your study participants? Request the recording and watch to tap into the discussion about recent research on the development of novel body composition phenotypes and more.
In this webinar, the featured speakers provide an introduction to Magnetic Resonance Imaging (MRI), and the MRI techniques used for body composition analysis. Request the recording and watch to learn how automatic image processing generates the measurements, see the advantages of volumetric MRI-based body and muscle composition measurements, and understand the utility of the measurements in a selection of applications and therapeutic areas.
Hepatology is the premier journal in the field of liver disease and the official journal of AASLD. AMRA is proud to be on the cover! Read about the ARRIVE trial in which AMRA’s whole-body composition analysis was used.
AMRA is featured in National Geographic’s global magazine. ‘The Future of Medicine’ and how personalized medicine is transforming our healthcare.
A magnetic resonance diagnostic software application enabling non-invasive evaluation of body composition.
AMRA Medical is introducing MAsS (Muscle Assessment Score) and AMRA®️ MAsS Scan (clearance expected in 2022) for clinicians to be able to assess sarcopenia more accurately and make critical decisions in patients being considered for organ transplant. Click on the video or read more here.
You need a reliable partner that understands your science, your workflow, and your needs. Whether you are designing your first clinical trial or are using MRI in clinical practice, you can elevate your team with AMRA’s skilled MRI experts.
Get the body composition data and services you need so you can focus on what matters most: your patients, your science, and your clinical decisions.
